deramciclane has been researched along with ritanserin in 2 studies
| Studies (deramciclane) | Trials (deramciclane) | Recent Studies (post-2010) (deramciclane) | Studies (ritanserin) | Trials (ritanserin) | Recent Studies (post-2010) (ritanserin) |
|---|---|---|---|---|---|
| 40 | 10 | 2 | 735 | 75 | 71 |
| Protein | Taxonomy | deramciclane (IC50) | ritanserin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0012 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.001 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| Diacylglycerol kinase alpha | Homo sapiens (human) | 9 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0025 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0025 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0012 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0025 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Détári, L; Gacsályi, I; Hajnik, T; Kukorelli, T; Szénási, G; Szentgyörgyi, V | 1 |
| Forsberg, MM; Kääriäinen, TM; Käenmäki, M; Lehtonen, M; Männistö, PT; Savolainen, J | 1 |
2 other study(ies) available for deramciclane and ritanserin
| Article | Year |
|---|---|
Differential EEG effects of the anxiolytic drugs, deramciclane (EGIS-3886), ritanserin and chlordiazepoxide in rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anticonvulsants; Camphanes; Chlordiazepoxide; Electroencephalography; Male; Mice; Rats; Rats, Wistar; Ritanserin; Sleep Stages | 1999 |
Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Buspirone; Camphanes; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Microdialysis; Motor Activity; Nucleus Accumbens; Rats; Rats, Wistar; Ritanserin | 2008 |